Captopril, the original ACEI, was developed after peptides in the Brazilian viper Bothrops jararaca’s venom were discovered to inhibit angiotensin converting enzyme.9 Angiotensin converting enzyme inhibitors prevent the breakdown of bradykinin, which may lead to the development of angioedema. Here, KNG1 is linked to angioedema.